Inventor · disambiguated record
Haiqun Jia
Also filed as: JIA HAIQUN
7 granted patents·10 pending applications·12 citations·filing 2017–2025
78Inventor score
Files withPHANES THERAPEUTICS INC13GENSUN BIOPHARMA INC2PHANES THERAPEUTIS INC1PHANESTHERAPEUTICS INC1
Top patents by PatentIndex Score
17 records- 0187US11555070B2Anti-claudin 18.2 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Jan 17, 2023·3 cites·16 claims
- 0286US12325745B2Anti-DLL3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2024·Granted Jun 10, 2025·0 cites·8 claims
- 0386US12037391B2Anti-DLL3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Jul 16, 2024·2 cites·9 claims
- 0486US11390679B2Anti-LAG-3 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2018·Granted Jul 19, 2022·4 cites·17 claims
- 0578US11873335B2Anti-folate receptor 1 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2019·Granted Jan 16, 2024·1 cites·13 claims
- 0678US10894823B2Trispecific inhibitors for cancer treatmentGENSUN BIOPHARMA INC·Filed 2017·Granted Jan 19, 2021·1 cites·7 claims
- 0778US2025257127A1Anti-DLL3 Antibodies and Uses ThereofPHANES THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0873US11401329B2Anti-CD47 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2018·Granted Aug 2, 2022·1 cites·17 claims
- 0960US2021115123A1Trispecific inhibitors for cancer treatmentGENSUN BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 1054US2025136703A1Anti-il13ra2 antibodies and uses thereofPHANES THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1153US2023089926A1Antibodies Conjugated with Fatty Acid Molecules and Uses ThereofPHANES THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1252US2024124574A1Bispecific Antibodies with Charge Pairs and Uses ThereofPHANES THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1352US2022411497A1Bispecific Antibodies with Alternatively Matched Interchain Cysteines and Uses ThereofPHANES THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1450US2022184127A1Humanized anti-dll3 chimeric antigen receptors and uses thereofPHANES THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1549US2022162301A1Humanized anti-folate receptor 1 chimeric antigen receptors and uses thereofPHANESTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1648US2022184126A1Humanized anti-claudin 18.2 chimeric antigen receptors and uses thereofPHANES THERAPEUTIS INC·Filed 2020·Application pending·0 cites
- 1748US2023220107A1Anti-Tumor Associated Antigen Antibodies and Uses ThereofPHANES THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haiqun Jia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →